Sinovac Biotech Ltd.
SVA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$258,355 | $88,131 | $14,458,911 | $185,179 |
| Dep. & Amort. | $144,745 | $156,597 | $86,832 | $4,037 |
| Deferred Tax | $76,324 | -$83,010 | $265,096 | -$11,227 |
| Stock-Based Comp. | $0 | $0 | $7,735 | $10,203 |
| Change in WC | $277,906 | -$1,081,188 | $460,615 | $282,795 |
| Other Non-Cash | -$134,602 | -$760 | $73,352 | $8,322 |
| Operating Cash Flow | $103,997 | -$770,745 | $15,352,541 | $479,309 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$145,688 | -$403,368 | -$719,977 | -$127,650 |
| Net Acquisitions | $39 | $8,917 | -$13,663 | $541,063 |
| Inv. Purchases | -$8,355,772 | -$11,658,465 | -$8,826,611 | -$201,688 |
| Inv. Sales/Matur. | $5,575,287 | $6,327,521 | $6,567,491 | $124,562 |
| Other Inv. Act. | $0 | -$35,075 | -$30,814 | -$541,043 |
| Investing Cash Flow | -$2,926,134 | -$5,760,470 | -$3,023,574 | -$204,756 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $238,842 | -$4,316 | -$26,138 | $33,003 |
| Stock Issued | $676 | $0 | $1,033 | $1,999 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$328,080 | -$263,171 | -$1,875,892 | $0 |
| Other Fin. Act. | $12,499 | $26,088 | $4,317 | $16,521 |
| Financing Cash Flow | -$76,063 | -$241,399 | -$1,896,680 | $592,566 |
| Forex Effect | -$114,901 | -$560,769 | $137,269 | $27,207 |
| Net Chg. in Cash | -$3,011,080 | -$7,333,383 | $10,569,556 | $894,326 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,286,377 | $11,619,760 | $1,050,204 | $155,878 |
| End Cash | $1,275,297 | $4,286,377 | $11,619,760 | $1,050,204 |
| Free Cash Flow | -$41,691 | -$1,174,113 | $14,632,564 | $351,659 |